Ki-67 immunostaining and prognosis in laryngeal cancer

Clinical Otolaryngology and Allied Sciences

Volumn 23, Issue 6, 1998, Pages 539-542

  Krecicki T ^a   Jelen M ^b   Zalesska Krecicka M ^b   Szkudlarek, T ^b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b NONE

Author keywords

Ki 67; Laryngeal cancer; Prognosis

Indexed keywords

KI 67 ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME; TISSUE SECTION;

EID: 0345003857     PISSN: 03077772     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2273.1998.2360539.x     Document Type: Article

References (16)

1. JONES A.S., ROLAND N.I., CASLIN A.M. et al. (1994) A comparison of cellular proliferation markers in squamous cell carcinoma of the head and neck. J. Laryngol. Otol. 108, 859-864
2. ROLAND N.J., CASLIN A.M., BOWIE G.L. et al. (1994) Has the cellular proliferation marker Ki-67 any clinical relevance in squamons cell carcinoma of the head and neck? Clin. Otolaryngol. 19, 13-18
3. GERDES J., LEMKE H., BAISCH H. et al. (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J. Immunol. 133, 1710-1715
4. VERHUIJEN R., KUIPERS H.I.F.I., SCHLINGEMANN R.O. et al. (1989) Ki-67 detects a nuclear matrix-associated proliferation-related antigen. 1: Intracellular localization during interphase. J. Cell. Sci. 92, 123-125
5. CROCKER J., MACARTNEY I.C. & SMITH J. (1988) Correlation between DNA flow cytometric and nucleolar organizer region data in non-Hodgkin's lymphomas. J. Pathol. 154, 151-156
6. BROWN D.C. & GATTER K.C. (1990) Monoclonal antibody Ki-67: its use in histopathology. Histopathology 17, 489-503
7. BERNARD N.J., HALL P.A., LEMOINE N.R. et al.(1987) Proliferative index in breast carcinoma determined in situ by Ki-67 immunostaining and its relationship to clinical and pathological variables. J. Pathol. 152, 287-295
8. HALL P.A., RICHARDS M.A., GREGORY W.M. et al. (1988) The prognostic significance of Ki-67 immunostaining in non-Hodgkins lymphoma. J. Pathol. 71, 1157-1160
9. MURAKARNI M., OHTANI I., HOJO H. et al. (1992) Immunohistochemical evaluation with Ki-67: an application to salivary gland tumours. J. Laryngol. Otol. 106, 35-38
10. YAMANAKA R., HARABUCHI Y. & KATAURA A. (1992) The prognostic value of Ki-67 antigen in Non-Hodgkin Lymphoma of Waldeyer ring and nasal cavity. Cancer 70, 2342-2349
11. WELKOBORSKY H.J., HINNI M., DIENES H.P. et al. (1995) Predicting recurrence and survival in patients with laryngeal cancer by means of DNA cytometry, tumor front grading, and proliferation markers. Ann. Otol. Rhinol. Laryngol. 104, 503-510
12. HAKE R., ECKEL H., VON PRITZBUER E. et al. (1995) Wertigkeit monoklonaler Antikorper (PC 10, MIB 1, p53 and LeuM 1) für die Abschatzung der Prognose von Patienten mit Plattenepithelkarzinomen des Larynx nach Laserteilresektion. Pathologie 16, 197-203
13. OGAWA Y., INOMATA T., NISHIOKA A. et al. (1992) Changes in the Ki-67 labeling rates of head and neck squamous cell carcinomas during preoperative radiation therapy. Oncology 49, 450-453
14. ZIDAR N., GALE N.C., CÖR A. et al. (1996) Expression of Ki-67 antigen and proliferative cell nuclear nuclear antigen in benign and malignant epithelial isions of the larynx. J. Laryngol. Otol. 110, 440-445
15. GOLUSIŃSKI W., SZMEJA Z., OLOESSON J. et al. (1996) Wartość diagnostyczna i prognostyczna onkogenu p53 wybranych markerów nowotworowych (Ki67, PCNA, DNA ploidii) ultrastruktury u chorych na raka krtani. Otolaryngol. Pol. 50, 607-617
16. LAM, K., LAW S., SO M. et al. (1996) Prognostic implication of proliferative markers MIB-1 and PC10 in esophageal squamous cell carcinoma. Cancer 77, 7-13